About Diarect
Diarect is a company based in Baden-baden (Germany) founded in 1998 by Bodo Liedvogel and Heinz Haubruck was acquired by BBI Group in June 2020.. The company has 289 employees as of January 31, 2022. Diarect operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Baden-baden, Germany
- Employees 289 as on 31 Jan, 2022
- Founders Bodo Liedvogel, Heinz Haubruck
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bbi Solutions Oem Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$700.09 K (USD), Grant
Jul 01, 2016
-
Investors
European Union
& 1 more
-
Employee Count
289
as on Jan 31, 2022
-
Acquired by
BBI Group
(Jun 04, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Diarect
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $700,085
-
First Round
First Round
(01 Jul 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Grant - Diarect | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Diarect
Diarect has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and BBI Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Instruments and reagents are supplied for diagnostic and healthcare sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Diarect
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Diarect
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diarect Comparisons
Competitors of Diarect
Diarect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Diarect
When was Diarect founded?
Diarect was founded in 1998 and raised its 1st funding round 18 years after it was founded.
Where is Diarect located?
Diarect is headquartered in Baden-baden, Germany. It is registered at Baden-baden, Baden-wurttemberg, Germany.
How many employees does Diarect have?
As of Jan 31, 2022, the latest employee count at Diarect is 289.
What does Diarect do?
Diarect specializes in the development and production of recombinant and native antigens that are used in the development of immunoassays. The company manufactures a host of allergens (found in food, grasses and trees), a large collection of autoimmune disease antigens (including, SARD, Mixed Connective Tissue Disease, SLE, Sjøgrens Syndrome, Systemic Sclerosis CREST Syndrome, Polymyositis Dermatomyositis, Autoimmune Thyroid Diseases, Celiac Disease, Autoimmune Hepatitis, Primary Biliary Cirrhosis, ANCA-Associated Diseases, Antiphospholipid Syndrome Thromboembolic Syndrome, Anti-GBM Disease, Diabetes Mellitus, Pernicious Anemia, Crohns Disease), and infectious disease antigens (including Anaplasmosis, Babesiosis, Borreliosis Lyme Disease Relapsing Fever, Candidiasis, Erythema infectiosum, Scarlet Fever, Yersiniosis). The company is also the European distributor of SurModics protein stabilization reagents and blockers and BioFX substrates.
Who are the top competitors of Diarect?
Diarect's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Diarect's investors?
Diarect has 2 investors. Key investors include European Union, and BBI Group.